Ind-Swift Laboratories (NSE:INDSWFTLAB) E10: ₹12.64 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDSWFTLAB Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
49 GF Score
Price ₹329.59
GF Value ₹51.28
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Ind-Swift Laboratories E10?

Ind-Swift Laboratories NSE:INDSWFTLAB -1.18% 49 E10 is ₹12.64 as of Jun. 2026. GuruFocus rates NSE:INDSWFTLAB with a GF Score™ of 49/100 and a GF Value™ of ₹51.28 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Ind-Swift Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹2.840. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹12.64 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Ind-Swift Laboratories's average E10 Growth Rate was 82.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-24), Ind-Swift Laboratories's current stock price is ₹329.59. Ind-Swift Laboratories's E10 for the quarter that ended in Jun. 2026 was ₹12.64. Ind-Swift Laboratories's Shiller PE Ratio of today is 26.08.

During the past 13 years, the highest Shiller PE Ratio of Ind-Swift Laboratories was 53.77. The lowest was 10.17. And the median was 17.33.


Ind-Swift Laboratories  (NSE:INDSWFTLAB) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ind-Swift Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=329.59/12.64
=26.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Ind-Swift Laboratories was 53.77. The lowest was 10.17. And the median was 17.33.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Ind-Swift Laboratories E10 Related Terms


Ind-Swift Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Ind-Swift Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ind-Swift Laboratories E10 Chart

Ind-Swift Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 6.90 9.77

Ind-Swift Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.94 6.92 6.92 9.77 12.64

NSE:INDSWFTLAB vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ind-Swift Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ind-Swift Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ind-Swift Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ind-Swift Laboratories's Shiller PE Ratio falls into.


NSE:INDSWFTLAB
49GF Score
Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ind-Swift Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ind-Swift Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.84/167.3573*167.3573
=2.840

Current CPI (Jun. 2026) = 167.3573.

Ind-Swift Laboratories Quarterly Data

per share eps CPI Adj_EPS
201212 -3.070 83.774 -6.133
201303 -8.960 85.687 -17.500
201403 0.000 91.425 0.000
201503 0.000 97.163 0.000
201603 0.000 102.518 0.000
201703 0.000 105.196 0.000
201803 0.000 109.786 0.000
201806 6.210 111.317 9.336
201809 0.660 115.142 0.959
201812 7.570 115.142 11.003
201903 -9.950 118.202 -14.088
201906 -2.910 120.880 -4.029
201909 -2.570 123.175 -3.492
201912 -0.980 126.235 -1.299
202003 0.440 124.705 0.590
202006 0.770 127.000 1.015
202009 1.680 130.118 2.161
202012 1.950 130.889 2.493
202103 -8.690 131.771 -11.037
202106 3.180 134.084 3.969
202109 4.140 135.847 5.100
202112 2.710 138.161 3.283
202203 -10.400 138.822 -12.538
202206 3.360 142.347 3.950
202209 4.290 144.661 4.963
202212 4.650 145.763 5.339
202303 -16.590 146.865 -18.905
202306 2.920 150.280 3.252
202309 5.360 151.492 5.921
202312 3.290 152.924 3.601
202403 83.550 153.035 91.370
202406 0.160 155.789 0.172
202409 0.670 157.882 0.710
202412 -0.820 158.323 -0.867
202503 31.240 157.552 33.184
202506 1.170 159.755 1.226
202509 0.960 162.289 0.990
202512 1.130 163.281 1.158
202603 1.760 164.272 1.793
202606 2.840 167.357 2.840

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹12.64 mean?
Ind-Swift Laboratories (NSE:INDSWFTLAB) has a E10 of ₹12.64 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ind-Swift Laboratories and its competitors.
Is Ind-Swift Laboratories' E10 too high?
Ind-Swift Laboratories' current E10 is ₹12.64. Overall, Ind-Swift Laboratories has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ind-Swift Laboratories' E10 compare to ZTS?
Ind-Swift Laboratories' E10 of ₹12.64 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Ind-Swift Laboratories and its competitors. Ind-Swift Laboratories's current E10 is ₹12.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ind-Swift Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ind-Swift Laboratories (NSE:INDSWFTLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹51.28, compared to a current price of ₹329.59 — trading 542.7% above its estimated fair value. The current E10 is ₹12.64. Ind-Swift Laboratories' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Ind-Swift Laboratories (NSE:INDSWFTLAB), the current E10 is ₹12.64 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ind-Swift Laboratories (NSE:INDSWFTLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ind-Swift Laboratories stock appears to be overvalued. The current stock price of ₹329.59 is trading 542.7% above its estimated GF Value™ of ₹51.28. GuruFocus considers Ind-Swift Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:INDSWFTLAB:

  • E10: ₹12.64
  • GF Value™: ₹51.28 vs. price of ₹329.59 (542.7% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the NSE:INDSWFTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ind-Swift Laboratories Business Description

Other Exchanges 532305:India
Address SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101
Ind-Swift Laboratories Ltd is involved in manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company serves various therapeutic segments, including Cardiovascular health, Antihistamines, Antidiabetics, Antipsychotics, Parkinson's disease, Antineoplastics, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitors. It operates solely in the pharmaceutical products sector. Geographically, the company supplies both domestic and international markets, with the majority of its revenue coming from outside India.
49GF Score

Get the complete analysis for NSE:INDSWFTLAB

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹329.59
Price
₹51.28
GF Value